telmisartan has been researched along with lomerizine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebina, J; Hanashiro, S; Hirayama, T; Ikeda, K; Ishikawa, Y; Iwasaki, Y; Kano, O; Kawabe, K; Kyuzen, M; Miura, K; Morioka, H; Nagasawa, J; Sawada, M; Takazawa, T; Yanagihashi, M | 1 |
1 other study(ies) available for telmisartan and lomerizine
Article | Year |
---|---|
Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Calcium Channel Blockers; Female; Humans; Japan; Male; Middle Aged; Migraine Disorders; Piperazines; Severity of Illness Index; Telmisartan | 2017 |